Abstract
Objective: Several studies have reported upward incidence trends of papillary thyroid cancer. It is unclear whether these trends reflect a real risk increase, by some attributed to iodine supplementation, or an artificial one, due to increased diagnostic activity or changed histological criteria. This study examines if these artificial factors explain the increased papillary thyroid cancer incidence in the Swiss canton of Geneva. Methods: All thyroid carcinomas (n = 436) recorded between 1970 and 1998 at the Geneva Cancer Registry were considered. European age-adjusted incidence trends were estimated using linear regression analysis. For papillary cancers we evaluated diagnostic modalities and way of presentation (in particular microcarcinoma < 1 cm or silent carcinoma). In addition, we reviewed the histological slides of follicular carcinomas. Results: Papillary thyroid cancer incidence increased significantly from 0.7 to 1.8/100,000 for men and from 3.1 to 4.3/100,000 for women between 1970–74 and 1995–98. The proportion of microcarcinomas and silent carcinomas increased from 17% to 24% between 1970–79 and 1990–98. At histological review, follicular cancers were more often reclassified as papillary cancer for cases diagnosed between 1970 and 1979 than for cases diagnosed between 1990 and 1998 (45% vs 25%, p = n.s.). Conclusions: The increasing papillary thyroid cancer incidence seems mainly due to changes in histological diagnostic criteria and, to a lesser extent, to increased diagnostic activity. If confirmed, the results of this study indicate that fears of increasing incidence rates of papillary thyroid cancer should not prevent implementation of adequate programs of iodine supplementation in the many areas where iodine deficiency still prevails.
Similar content being viewed by others
References
Ron E (1996) Thyroid cancer. In: Schottenfeld D,Fraumeni JF, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press, pp. 1000-1021.
Franceschi S,Boyle P,Maisonneuve P,La Vecchia C,Burt AD,Kerr DJ, et al. (1993) The epidemiology of thyroid carcinoma. Crit Rev Oncol 4: 25-52.
Levi F,Franceschi S,Te VC,Negri E,La Vecchia C (1990) Descriptive epidemiology of thyroid cancer in the Swiss Canton of Vaud. J Cancer Res Clin Oncol 116: 639-647.
Pettersson B,Adami HO,Wilander E,Coleman MP (1991) Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer 48: 28-33.
Feldt-Rasmussen U (2001) Iodine and cancer. Thyroid 11: 483-486.
Hedinger C,Sobin LH (1974) Histological Typing of Thyroid Tumours. International histological classification of tumours, No. 11. Geneva: World Health Organization.
Hedinger C,Williams ED,Sobin LH (1988) Histological Typing of Thyroid Tumours, 2nd edn. Berlin: Springer Verlag.
Bouchardy C (1997) Switzerland, Geneva. In: Parkin DM,Whelan SL,Ferlay J, et al., eds. Cancer Incidence in Five Continents, Vol. VII. Lyon: International Agency for Research on Cancer, pp. 666-669.
World Health Organization (WHO)(1976) ICD-O: International Classification of Diseases for Oncology. 1st edn. Geneva: WHO.
Francis B, Green M, Payne C, et al., eds. (1992) GLIM 4. London: Royal Statistical Society.
Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the Thyroid Gland. AFIP Atlas of Tumor Pathology, No. 5. Washington, DC: Armed Forces Institute of Pathology.
Franceschi S,La Vecchia C (1994) Thyroid cancer. In: Doll R,Fraumeni JF Jr,Muir CS, eds. Trends in Cancer Incidence and Mortality, Vol. 19/20. Cold Spring Harbor: Cold Spring Harbor Press, pp. 393-424.
Merke F (1984) History and Iconography of Endemic Goitre and Cretinism. Bern: Hans Huber Verlag.
Bacher-Stier C,Riccabona G,Totsch M,Kemmler G,Oberaigner W,Moncayo R (1997) Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7: 733-741.
Pukkala E (1995) Cancer risk by social class and occupation: a survey of 109,000 cancer cases among Finns of working age. Contributions to Epidemiology and Biostatistics. Basel: Karger.
Petterson B,Coleman MP,Ron E,Adami HO (1996) Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histological type. Int J Cancer 65: 13-19.
Lindsay RS,Toft AD (1997) Hypothyroidism. Lancet 349: 413-417.
Lazarus JH. Hyperthyroidism (1997) Lancet 349: 339-343.
Saxen E,Franssila K,Bjarnason O,Normann T,Ringertz N (1978) Observer variation in histologic classification of thyroid cancer. Acta Pathol Microbiol Scand 86: 483-486.
Valeix P,Zarebska M,Preziosi P,Galan P,Pelletier B,Hereberg S (1999) Iodine deficiency in France. Lancet 353: 1766-1767.
Delange F,Benker G,Caron Ph, et al. (1997) Thyroid volume and urinary iodine in European school children: standardization of values for assessment of iodine deficiency. Eur J Endocrinol 136: 180-187.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verkooijen, H.M., Fioretta, G., Pache, JC. et al. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14, 13–17 (2003). https://doi.org/10.1023/A:1022593923603
Issue Date:
DOI: https://doi.org/10.1023/A:1022593923603